UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington 20549
SCHEDULE
13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)
CALCIMEDICA,
INC.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
38942Q 202
(CUSIP
Number)
Valence Investments SPV IV, LLC
Valence Investments SPV V, LLC
Valence Investments SPV VI, LLC
Eric Roberts
Rachel
Leheny
590 Madison Avenue, 21st Floor
New York, NY 10022
(212)
521-4379
with copy to:
Evan Ng
Dorsey & Whitney LLP
167 Hamilton Avenue, Suite 200
Palo Alto, CA 94301
(650) 565-2252
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
November 7, 2023
(Date of Event Which Requires Filing of this Statement)
If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box. ☐
Note: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* |
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).